Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2005 Abstracts: A Previous Treatment with Botulinum Toxin Injections Jeopardizes the Final Results of Subsequent Laparoscopic Heller Myotomy for Esophageal Achalasia
Back to 2005 Posters
Back to 2005 Program and Abstracts
A Previous Treatment with Botulinum Toxin Injections Jeopardizes the Final Results of Subsequent Laparoscopic Heller Myotomy for Esophageal Achalasia
Mario Costantini, Giovanni Zaninotto, Giuseppe Portale, Emanuela Guirroli, Christian Rizzetto, Loredana Nicoletti, Renato Salvador, Martina Ceolin, Ermanno Ancona, Department of Medical and Surgical Sciences, University of Padua, Padova, Outside US, Italy

In the past decade, laparoscopic Heller myotomy has emerged as the primary treatment of choice for patients with esophageal achalasia. However, some patients are still referred for surgery only after an unsuccessful endoscopic treatment with dilations or Botulinum toxin (BT) injections. This may result in a more difficult operation with a higher risk of mucosal perforation, and eventually affect the final results of the surgical treatment. In this study we evaluated the effects of a previous endoscopic treatment on the final outcome of surgery in 225 patients who underwent laparoscopic Heller-Dor operation for achalasia from 1992 to June 2004. They were 121 male, 104 female; their median age was 42 years (range 11-80). All the operations were performed by 4 staff surgeons. The majority of the patients (181) underwent surgery without any previous treatment (Group A), whereas 18 had 1 to 4 pneumatic dilations (Group B) and 26 had BT treatment (alone in 22, associated to dilations in 4) (Group C). No differences in the frequency of intraoperative mucosal lesions were detected among the 3 groups (5/181 mucosal lesions in group A, 0/18 in group B and 1/26 in group C, p=n.s.) nor in the median duration of the operation (152 +-34 min, 148 +- 31 min, 139 +- 29 min for group A, B & C, respectively, p=n.s.), even if a subjective impression of a more difficult operation was experienced by all the surgeons in patients of group B and C. None of the patients was lost to follow up. Six patients died for unrelated causes 18 to 69 months after the operation. Median follow-up was 44 months (range 1-131). The 5-year actuarial control of dysphagia showed no differences between patients of group A and B (88% and 92%, respectively); however, only 70% of patients of group C were free of symptoms at 5 years. This finding was even more evident if patients who received BT and dilations were considered separately (50% of dysphagia-free patients at 5 years, p<0.05). Further, a previous treatment with BT significantly correlated with a poor outcome after surgery at logistic regression analysis.

In conclusion, a previous endoscopic treatment with BT(especially if associated with dilations), but not dilations alone, jeopardizes the final results of laparoscopic Heller myotomy for acalasia. This should be kept in mind when designing the therapeutic plan for these patients.


Back to 2005 Posters
Back to 2005 Program and Abstracts


Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards